Table 1.
Breast Cancer Tissue Microarray: Clinicopathological Details.
| Stained for Tip60 N (%) | |
|---|---|
| Age | |
| Pre/Peri-menopausal | 93 (30.7%) |
| Post-menopausal | 210 (69.3%) |
| Total (n=) | 303 |
| Subtype | |
| Luminal A | 119 (35.3%) |
| Luminal B | 28 (8.3%) |
| Her2 positive | 16 (4.8%) |
| Basal | 64 (19%) |
| Unknown | 110 (32.6%) |
| Total (n=) | 337 |
| Receptor Status | |
| ER Positive | 102 (33.3%) |
| ER Negative | 204 (66.7%) |
| Total (n=) | 306 |
| PR positive | 115 (38.1%) |
| PR Negative | 187 (61.9%) |
| Total (n=) | 302 |
| Her2 positive | 186 (81.6%) |
| Her2 negative | 42 (18.4%) |
| Total (n=) | 228 |
| Stage | |
| 1 | 65 (21.8%) |
| 2 | 139 (46.6%) |
| 3 | 73 (24.5%) |
| 4 | 21 (7%) |
| Total (n=) | 298 |
| N Score | |
| 0 | 142 (45.8%) |
| 1 | 92 (29.7%) |
| 2 | 55 (17.7%) |
| 3 | 21 (6.8%) |
| Total (n=) | 310 |
| Metastatic disease | |
| No | 295 (93.7%) |
| Yes | 20 (6.3%) |
| Total (n=) | 315 |